Financial Results, Appointments, Recognitions, New Clinical Offering, and Updated Revenue Guidance - Analyst Notes on Red Hat, FireEye, Workday, Catamaran and Synaptics

NEW YORK , June 24, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Red Hat, Inc. (NYSE: RHT), FireEye, Inc. (NASDAQ: FEYE), Workday, Inc. (NYSE: WDAY), Catamaran Corporation (NASDAQ: CTRX) and Synaptics, Incorporated (NASDAQ: SYNA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: . -- Red Hat, Inc. An alyst Notes On June 18, 2014 , Red Hat, Inc. (Red Hat) reported its Q1 FY 2015 financial results (period ended May 31, 2014 ). Quarterly revenues increased 16.7% YoY to $424.0 million . However, net income registered $37.7 million or $0.20 per diluted share, compared with $40.4 million , or $0.21 per diluted share, in Q1 FY 2014. According to the Company, the growth in quarterly revenues resulted from the increase in subscription revenue, up 17.8% YoY to $372.0 million . Commenting on the results, Jim Whitehurst , President and CEO of Red Hat, said, "Our strong start to FY15 is a direct result of our ability to consistently deliver meaningful value to enterprise customers. We now count 94% of the Fortune 500 and 90% of the Fortune Global 500 as customers." He added, "As evidence of this demand and Red Hat's strong market position, we closed a record number of first quarter deals of a million dollars or more." The full analyst notes on Red Hat are available to download free of charge at: -- FireEye, Inc. Analyst Notes On June 19, 2014 , FireEye, Inc. (FireEye) announced the appointment of Shane McGee , former General Counsel and Vice President of Legal Affairs at Mandiant, as Chief Privacy Officer. The Company stated that in his new role Mr. McGee will be responsible for growing and governing a new global privacy program that will establish data protection standards and lead industry improvement initiatives. FireEye informed that the program will work with governing bodies, businesses, and employees worldwide to build regulatory practices that meet local needs while enabling the advancement of global cyber security. Further as part of the program, FireEye will demonstrate how intelligence sharing strengthens consumer privacy and security, and will also determine best practices for information sharing in the event a breach to improve remediation outcomes. David DeWalt , Chairman of the Board and CEO, FireEye said, "Shane's experience and background make him the perfect choice to assure both our employees and our customers that private information is secure and being handled responsibly in all circumstances." The full analyst notes on FireEye ar e available to download free of charge at: -- Workday, Inc. Analyst Notes On June 16, 2014 , Workday, Inc. (Workday) announced that it ranked first for the fourth consecutive year among large companies on the annual list of the Bay Area News Group's Top Workplaces. According to the Company, the Bay Area News Group's Top Workplaces is determined based solely on employee feedback and the employee survey is conducted by WorkplaceDynamics, LLP, a research firm on organizational health and employee management. Ashley Goldsmith , Chief Human Resources Officer, Workday, said, "Our employees are at the center of Workday's success, and this honor is a direct reflection of the positive and rewarding culture that they have helped to cultivate." The full analyst notes on Workday are available to download free of charge at: -- Catamaran Corporation Analyst Notes On June 16, 2014 , Catamaran Corporation (Catamaran) announced the launch of the Safe & Effective Compound Use Reassurance Effort (SECURE), its newest clinical service offering aimed at helping clients to better monitor and manage compound medications. Catamaran informed that the commercial clients of the Company will be allowed to tailor the new offering to their specific needs. Sumit Dutta , M.D. M.B.A. Senior Vice President and Chief Medical Officer, Catamaran, said, "Compound medications play a role in helping address clinical needs for certain patients. However, given the lack of oversight in this area and the safety concerns we have seen with compounding in the past couple of years, we want to make sure our clients have access to the tools needed to ensure safety and cost effectiveness." The full analyst notes on Catamaran are available to download free of charge at: -- Synaptics, Incorporated Analyst Notes On June 10, 2014 , Synaptics, Incorporated (Synaptics) updated its revenue outlook for Q4 FY 2014 (period ending June 30, 2014 ). The Company stated that it expects quarterly revenue to be in the range between $300.0 million to $310.0 million , up from its previous guidance of $275.0 million to $295.0 million . Meanwhile, the Company expects full-year FY 2014 revenue to be in the range between $933.0 million to $943.0 million , up 41% to 42% YoY. In other news, on the same day the Company announced that it signed a definitive merger agreement to acquire all of outstanding equity of Renesas SP Drivers, Inc., a leader in small and medium-size display driver ICs (DDICs) for smartphones and tablets. The full analyst notes on Synaptics are available to download free of charge at: -- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership. =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli , a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] . 5. For any urgent concerns or inquiries, please contact us at compliance [at] . 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli , CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. SOURCE Analysts Review